Dr Dane Horsfall FACEM    Cabrini Hospital
   Literature extensive   Listen to this talk!   Journal watch-http://emergency-medicine.jwatch.org/   EM:RAP-http://w...
   NINDS 1995/ECASS III 2008   Rivers 2001/Surviving Sepsis 2008 + Case   USA vs Canada: NEXUS 2001/Canadian    Cervica...
   National Institute of Neurological Disorders    and Stroke-Washington DC   “t-PA for acute ischemic stroke”   Random...
   NIHSS-National Institutes of Health Stroke Scale    ◦ neuro deficit, 42-point scale, neurologic deficits in 11 categor...
   Part 1 291pts NIHSS score at 24hrs= no    difference   Part 2 333pts Combination score at 3/12   Results combined fo...
   European Cooperative Acute Stroke Study   “Thrombolysis with Alteplase 3 to 4.5 Hrs after    Acute Ischemic Stroke” ...
   Contraindications:    ◦ Bleeding risk      Anticoagulants, Platelets <100      Massive CVA > 1/3 cerebral hemisphere...
   263 pts Rx in ED for 6/24 prior to ICU:    ◦   130 EGDT    ◦   133 standard Rx    ◦   In hospital Mortality EGDT 30%, ...
   Funded by manufacturer of CVC   High control mortality   Dr Rivers managing pts in ED   Continuous Scv O2sats not p...
   EGDT   Antibiotic within 1 hr   Source Control   crystalloid or colloid fluid resuscitation   Vasopressor = Noradr...
BIBA at 0430 - fever and severe R leg pain since 0100PHx CLL/Neutropenia - treated with gCSF0435-Temp         400CBP      ...
Two peripheral IVs,IV Tazocin            4.5g (early broad spectrum antis✔)IV fluid              N/saline 1000mls (filling...
   Persistent hypotension, SBP 70-90/DBP 50-60   Remained in AF   Pain very difficult to control   Temp 38.4   0720-H...
   0845             IDC   0900             IV Metaraminol increments   0930             IV Gelofusine then IV Albumin ...
   National Emergency X-ray Utilization Study    (Jerry Hoffman UCLA)   34,000pts, 21 sites, prospective observation    ...
   9000pts normal conscious state**   Sens 100%, spec 45%   1. High risk factors    ◦ age>65    ◦ Mechanism (fall>1m,ax...
   Advantages    ◦ Mechanism    ◦ Age >65   Disadvantages    ◦ Complicated    ◦ No distracting injury*
   A comparison of Albumin and Saline for fluid    resus in ICU (Saline vsAlbumin Fluid    Evaluation)   Multicentre, ra...
   “Early treatment with prednisolone or acyclovir in    Bells palsy”   Double-blind, placebo-control, randomized trial...
   Recovery at 3/12    ◦ Pred 83% vs no Pred 64%    ◦ Acyclovir 71% vs no Acyclovir 75%    ◦ Both 80%   Recovery at 9/12...
   “Sensitivity of CT < 6/24 H/A onset for Dx    SAH: prospective cohort study”   3100 pts, 11 Hospitals, 2000-2009   A...
   Urgent CT (Cabrini CT ?3rd Gen)   ?to LP or not to LP – depends on case and    discussion with patient   Perry study...
   NINDS - “t-PA for acute ischemic stroke”, N Engl J Med    1995;333:1581-7   ECASS III – “Thrombolysis with Alteplase ...
   Stiell IG et al, “The Canadian C-spine rule for radiography in    alert and stable trauma Patients”, JAMA. 2001 Oct   ...
Emergency medicine research
Emergency medicine research
Upcoming SlideShare
Loading in …5
×

Emergency medicine research

833 views

Published on

Discussion of some important EM research

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
833
On SlideShare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Emergency medicine research

  1. 1. Dr Dane Horsfall FACEM Cabrini Hospital
  2. 2.  Literature extensive Listen to this talk! Journal watch-http://emergency-medicine.jwatch.org/ EM:RAP-http://www.emrap.org/ Landmark Trials -Trials that affect our practice
  3. 3.  NINDS 1995/ECASS III 2008 Rivers 2001/Surviving Sepsis 2008 + Case USA vs Canada: NEXUS 2001/Canadian Cervical Spine 2001 SAFE 2004 Sullivan 2007 Perry/Steill SAH 2011
  4. 4.  National Institute of Neurological Disorders and Stroke-Washington DC “t-PA for acute ischemic stroke” Randomized, Double Blinded, recombt-PA (Alteplase) tPA 0.9mg/kg(max 90mg) 10% bolus then inf 1/24 Recommended tPA< 3/24
  5. 5.  NIHSS-National Institutes of Health Stroke Scale ◦ neuro deficit, 42-point scale, neurologic deficits in 11 categories. Eg mild facial paralysis = 1, complete right hemiplegia/aphasia =25. Barthel Index ◦ perform activities of daily living (eating, bathing, walking, toilet) out of 100 Modified Rankin Scale-overall assessment of function ◦ 0= asymptomatic up to 5 =severe disability Glasgow Outcome Scale-global assessment of function ◦ 1=good recovery, ◦ 2=moderate disability ◦ 3=severe disability ◦ 4=vegetative state ◦ 5=death
  6. 6.  Part 1 291pts NIHSS score at 24hrs= no difference Part 2 333pts Combination score at 3/12 Results combined for analysis t-PA minimal/no disability scores- 12% absolute increase, 32% relative, in, NNT=8 t-PA Increase ICH by 6% NNH=17 ◦ Assoc with more severe isch strokes/more oedema on CT Mortality t-PA 17%, Placebo 21% (Not stat. significant)
  7. 7.  European Cooperative Acute Stroke Study “Thrombolysis with Alteplase 3 to 4.5 Hrs after Acute Ischemic Stroke” 821pts tPA 3-4.5 hrs 90 day disability –modified Rankin Scale ◦ 0-1 no disability t-PA 52% vsPlac 45% - NNT 14 ◦ 2-6 disability ICH(symp) t-PA 2.4% vsPlac 0.2% - NNH 45 Mortality t-PA 7.7% vsPlac 8.4% no difference BUT studies showing no Difference: ◦ ECASS I 1995 620pts tPA< 6/24 ◦ ECASS II 1998 300pts 0-6hrs
  8. 8.  Contraindications: ◦ Bleeding risk  Anticoagulants, Platelets <100  Massive CVA > 1/3 cerebral hemisphere-obtund/complete hemiplegia  Uncontrolled HT >185/110  CVA/Head Injury in last 3/12 or ICH at an time  Bleed in last 3/52, bleeding diathesis, arterial puncture last 7/7  Pregnancy  Trauma/Surgery in last 14/7 ◦ Not Stroke:  Seizures  Hypoglycaemia ◦ No significant improvement possible  Resolving stroke  Previous disability
  9. 9.  263 pts Rx in ED for 6/24 prior to ICU: ◦ 130 EGDT ◦ 133 standard Rx ◦ In hospital Mortality EGDT 30%, Standard 46% ◦ NNT 6 EGDT: ◦ CVP 8-12mmHg if < Fill 500ml bolus N/S every 30 mins ◦ MAP >65mmHg if <vasopressorsNoradrenaline ◦ ScvO2 (central mixed venous O2 sat) >70% if <Tx RBC to Hct> 30% if ScvO2 still <inotropes(dobutamine)  Central venous Sats>70% surrogate marker of adequate tissue perfusion-ie adequate resus from septic shock
  10. 10.  Funded by manufacturer of CVC High control mortality Dr Rivers managing pts in ED Continuous Scv O2sats not practical to measure Cant argue against concept
  11. 11.  EGDT Antibiotic within 1 hr Source Control crystalloid or colloid fluid resuscitation Vasopressor = Noradrenaline Dobutamine if CO low post filling/vasopressors Stress-dose steroid only if BP poorly responsive to vasopressors
  12. 12. BIBA at 0430 - fever and severe R leg pain since 0100PHx CLL/Neutropenia - treated with gCSF0435-Temp 400CBP 87/62 mmHgHR 160/min irregular (AF)RR 17/minO2 sat 95% (air)Right leg red / swollen to thigh “Cellulitis”
  13. 13. Two peripheral IVs,IV Tazocin 4.5g (early broad spectrum antis✔)IV fluid N/saline 1000mls (filling✔)IV analgesia Morphine incrementsIV Digoxin 500 mcg
  14. 14.  Persistent hypotension, SBP 70-90/DBP 50-60 Remained in AF Pain very difficult to control Temp 38.4 0720-Hypotension persists 80/50 Rx-Gelofusine 500 and further 1000 ml N/Saline (Filling✔)
  15. 15.  0845 IDC 0900 IV Metaraminol increments 0930 IV Gelofusine then IV Albumin 1000 CVC (1000, IJV) CVP 28-30-well filled ✔ 1035 Noradrenalineinf -Vasopressor ✔ 1200 IV Vancomycin 1g 1220 Transfer ICU Non EGDT-central venous sats, Survivng sepsis- Source control Outcome ◦ Clinical Dx Necrotizing Fasciitis by ID, pt palliated deceased later that day in ICU
  16. 16.  National Emergency X-ray Utilization Study (Jerry Hoffman UCLA) 34,000pts, 21 sites, prospective observation of decision tool: Sens>99% Spec 12% If none of 5 clinical signs=clear Cx spine ◦ Midline tenderness ◦ Distracting injury ◦ Altered GCS ◦ Neurology ◦ Intoxication
  17. 17.  9000pts normal conscious state** Sens 100%, spec 45% 1. High risk factors ◦ age>65 ◦ Mechanism (fall>1m,axial,MCA >100km/hr, motorbike, bicycle) ◦ Neuro* 2. Low Risk factors ◦ low speed MCA ◦ sitting/ walking ◦ no midline tenderness*/delayed pain 3. Able to Laterally neck rotation 45 degrees?
  18. 18.  Advantages ◦ Mechanism ◦ Age >65 Disadvantages ◦ Complicated ◦ No distracting injury*
  19. 19.  A comparison of Albumin and Saline for fluid resus in ICU (Saline vsAlbumin Fluid Evaluation) Multicentre, randomised, double blinded, 7000pts 4% Alb vs N/Saline 28/7- no difference in mortality Conclusion- Use N/Saline
  20. 20.  “Early treatment with prednisolone or acyclovir in Bells palsy” Double-blind, placebo-control, randomized trial 500 Pts with Bells (no Herpes vesicles) < 72 hrs onset 10/7 Rx with: ◦ Pred 25mg bd ◦ Acyclovir ◦ Both ◦ Placebo Rating facial paralysis at 3 and 9/12 with “House-Brackmann scale” (1 normal to 6 total paralysis)
  21. 21.  Recovery at 3/12 ◦ Pred 83% vs no Pred 64% ◦ Acyclovir 71% vs no Acyclovir 75% ◦ Both 80% Recovery at 9/12 ◦ Pred 94% vs no Pred 82% ◦ Acyclovir 85% vs no Acyclovir 91% ◦ Both 93% Conclusion-Give Prednisolone!!! Supported by results from: T Berg et al “The Effect of Prednisolone on Sequelae in Bells Palsy” Arch Otolaryngololgy - Head Neck Surg. 2012;138(5):445-449 May 2012
  22. 22.  “Sensitivity of CT < 6/24 H/A onset for Dx SAH: prospective cohort study” 3100 pts, 11 Hospitals, 2000-2009 Adults, New acute h/a, no abNNeuro-?SAH 240 SAH (8%) Overall CT(3rd Gen) 93% sensitive, 100%specific Subgroup 950pts CT < 6/24 100% sens/specific (Dx all 121 SAH) ie Normal CT <6/24 rules oot SAH
  23. 23.  Urgent CT (Cabrini CT ?3rd Gen) ?to LP or not to LP – depends on case and discussion with patient Perry study not validated in Australia-unlikely to be repeated Some ED’s have changed protocols
  24. 24.  NINDS - “t-PA for acute ischemic stroke”, N Engl J Med 1995;333:1581-7 ECASS III – “Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke” N Eng J Med 2008;359:1317 Rivers et al – “Early goal-directed therapy in the treatment of severe sepsis and septic shock”, N Engl J Med, 345(19):1368- 77, 2001 Nov 8. Surviving Sepsis–Dellinger RP et al. January 2008 "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008". Intensive Care Med 34 (1): 17–60. NEXUS – J Hoffman and The National Emergency X-Ray Utilization Study Group – “Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma”, N Engl J Med 2000;343:94-9
  25. 25.  Stiell IG et al, “The Canadian C-spine rule for radiography in alert and stable trauma Patients”, JAMA. 2001 Oct 17;286(15):1841-8 SAFE – “A Comparison of Albumin and Saline for Fluid Resuscitation in the ICU”, N Engl J Med 2004;350: 2247-56. Sullivan et al – “Early treatment with prednisolone or acyclovir in Bells palsy”, N Engl J Med. 2007 Oct 18;357(16):1598-607 “The Effect of Prednisolone on Sequelae in Bells Palsy” Arch Otolaryngology Head Neck Surg. 2012;138(5):445-449 May 2012 Perry/Steill et al – “Sensitivity of CT performed within six hours of onset of headache for diagnosis of SAH: prospective cohort study” , BMJ 2011 July18;343:d4277

×